pathos
PrivateLast Round
Series D
5/15/2025
Last Round Size
$365M
Est. Valuation
$1.6B
Total Funding Raised
$467M
Company Overview
Pathos is a biotechnology company that offers a drug discovery platform designed to expedite the medication development process through the use of big data, technology, and artificial intelligence for target identification and validation.
Sector
Biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
pathos Comps
Related companies by embedding similarity.
pathos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | 5/15/2025 | ||||
| Series C | 10/29/2024 | ||||
| Series B | 3/2/2023 | ||||
| Series A | 7/1/2021 |
pathos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about pathos's valuation, stock price, and market status.
